Activity of eribulin in patients with advanced liposarcoma demonstrated in a subgroup analysis from a randomized phase III study of eribulin versus dacarbazine

George D. Demetri, Patrick Schöffski, Giovanni Grignani, Jean Yves Blay, Robert G. Maki, Brian A. Van Tine, Thierry Alcindor, Robin L. Jones, David R. D’Adamo, Matthew Guo, Sant Chawla

Research output: Contribution to journalArticlepeer-review

116 Scopus citations

Fingerprint

Dive into the research topics of 'Activity of eribulin in patients with advanced liposarcoma demonstrated in a subgroup analysis from a randomized phase III study of eribulin versus dacarbazine'. Together they form a unique fingerprint.

Medicine & Life Sciences